Stier, M.D., from the Boston University School of Medicine, and colleagues used data from the multicenter AIDS Malignancy Consortium 084 study to evaluate the prevalence of and risk factors for anal
HSILs among 256 WLHIV (median age, 49.4 years).
The histopathologic features of bowenoid papulosis overlap significantly with those of basaloid
HSIL (Bowen disease).
It also included 4 cases of AGUS, 3 cases were of LSIL, 7 cases were of
HSIL and 2 cases were of invasive squamous cell carcinoma and 1 case of adenocarcinoma cervix.
It was specimens of SCC derived from patients who had undergone total hysterectomy, and
HSIL specimens were derived from patients who had undergone the loop electrosurgical excision procedure (LEEP) or cone biopsy.
One case of
HSIL was observed in Grade I and Grade II of p53 expression comprising 50.00% of cases each.
None of the women with serial Pap smears progressed to
HSIL. The majority of women (34,77%) with a negative or ASCUS first Pap did not progress beyond ASCUS.
In our follow-up of 54 unsatisfactory anal Pap cases with biopsy follow-up, distribution of squamous intraepithelial lesions (57.4%),
HSIL (19%), and negative cases was not statistically significant when compared with that of Morency et al.
Cell experts rated the anal cell samples according to a standard system that starts with normal cells and progresses to high-grade squamous intraepithelial neoplasia (
HSIL), which can lead to anal cancer (Figure 1).